眼内容剜除联合多孔羟基磷灰石义眼座植入术临床分析

目的：评价眼内容剜除术联合羟基磷灰石（Hydroxyapatite HA)义眼座植入术的疗效和安全性。方法：1998．1－2000．5在本中心接受眼内容剜除联合HA植入术的78例病例进行回顾性分析。收集各病例临床资料、手术指征、义眼座的大小、手术疗效和术后并发症。平均随诊时间11．6月（2－24月）。结果：本组共78例患者接受眼内容剜除联合HA植入术，全部病例均获得手术成功。术后无一例患者出现义眼座外露、脱出、移位等并发症。随诊期间无交感性眼炎发生。结论：在严格选择手术适应症的条件下，眼内容剜除术联合HA后置植入术是一种安全而有效的治疗部份无光感疼痛性眼球或萎缩眼球的方法。

Clinical Analysis of Evisceration with Hydroxyapatite Implant

Purpose: To evaluate the clinical effect and safety of evisceration with hydroxyapatite (HA) orbital implant. Methods: A retrospective analysis of all eviscerations with HA implant performed between January 1998 and May 2000 in Zhongshan Ophthalmic Center was completed. Patient records were reviewed for demographic data, surgical indication, sphere size, clinical outcome, and complications. The average follow - up interval was 11.6 months (2-24 months). Results: Primary evisceration with HA implantation was performed in total 78 cases. All patients underwent successful surgery without major complications. There was no case with those complications,including implant extrusion ,exposure and implant dislocation, in the series examination. No patient has symphathetic ophthalmia during follow - up interval. Conclusion: In strict selected cases with surgical indication of evisceration, primary evisceration with HA implantation is a safe and effective method for treating patients with a blind, painful or atrophic eye. Eye Science 2000; 16: 267-269.